The Golden Rice humanitarian project has been recognized in the top 10 biotech projects, as one of the most influential projects of the past 50 years by Project Management Institute (PMI) in its 2019 Most Influential Projects list. Golden Rice is the only plant-based biotech project listed, although it shares its health applications with the other nine in the list.

The purpose of the Most Influential Projects list is to raise awareness of the positive impact that project work has had on the world. More than 1,000 projects were considered by a group 400 leaders in the global project management community, including PMI chapter leaders and members, as well as academics and industry experts to determine the list of the Top 50 Most Influential Projects. Additionally, PMI has released lists of the top 10 most influential projects across 14 categories in a variety of regions and industries, including a broadly-based biotechnology category.

In 2000, the technology behind Golden Rice was donated by its inventors Ingo Potrykus and Peter Beyer to assist the resource poor of the world. Golden Rice is an additional intervention and a disruptive technology for use against vitamin A deficiency, a major public health issue and the most significant cause of child mortality and blindness globally. Currently, Golden Rice is registered as safe in Australia, Canada, New Zealand, and the United States.

Press release

More News right arrow

A low-carb diet may lower the risk of blinding eye disease

Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may reduce the risk of the most common subtype of glaucoma, according to a study published in Eye-Nature.

A low-carb diet may lower the risk of blinding eye disease

Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may reduce the risk of the most common subtype of glaucoma, according to a study published in Eye-Nature.

FDA announces qualified health claim for cranberry products and urinary tract infections

The U.S. FDA has announced in a letter of enforcement discretion that it does not intend to object to the use of certain qualified health claims regarding consuming certain cranberry products and a reduced risk of recurrent urinary tract infection in healthy women.

FDA announces qualified health claim for cranberry products and urinary tract infections

The U.S. FDA has announced in a letter of enforcement discretion that it does not intend to object to the use of certain qualified health claims regarding consuming certain cranberry products and a reduced risk of recurrent urinary tract infection in healthy women.

Call to action for stronger, better-funded federal nutrition research

According to a group of research, policy, and government experts, the United States needs to strengthen and increase funding for federal nutrition research and improve cross-governmental coordination in order to accelerate discoveries, grow the economy, and—most importantly—improve public health, food/nutrition security, and population resilience.

IFT Weekly Newsletter

Rich in industry news and highlights, the Weekly Newsletter delivers the goods in to your inbox every Wednesday.

Subscribe for free